Ross Dehmoobed

Share

facebook-icon linkedin-icon twiter-icon pinterst-icon

Ross Dehmoobed

Ross Dehmoobed
ClariMed Appoints Ross Dehmoobed as Vice President of Software; Expands Digital Health Services Offering

ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, has appointed Ross Dehmoobed as Vice President of Software and Digital Services. 

This strategic leadership addition coincides with the company’s expanded focus on delivering comprehensive digital health solutions.

With nearly 20 years of experience in software engineering and leadership across safety-critical and regulated industries - including medical devices and automotive - Ross brings deep technical expertise and a proven track record of innovation. His background spans a wide range of domains, including in vitro diagnostics (IVD), patient monitoring, cell therapy, and digital pathology, where he has consistently delivered secure, scalable, and regulatory-compliant software solutions.

In his new role, Ross will lead ClariMed’s software and digital services strategy, focusing on building a high-performance team and driving innovation across areas such as software development, UX/UI design, AI/ML, cloud connectivity, and cybersecurity. 

His leadership will be key in advancing ClariMed’s mission to revolutionize healthcare and diagnostics through cutting-edge digital platforms that prioritize user needs and regulatory excellence.

Prior to joining ClariMed, Ross served as Vice President of Software and Platforms at Veranex (formerly Fusion Biotec), where he played an instrumental role in scaling multidisciplinary teams and developing end-to-end software solutions spanning embedded, mobile, cloud, and web applications. His commitment to quality and security helped ensure the delivery of high-impact, compliant products across regulated healthcare markets.

Ross Dehmoobed’s appointment underscores ClariMed’s dedication to evolving its digital health capabilities while continuing to deliver exceptional value and innovation to clients across the medical technology landscape.